Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
82 Leser
Artikel bewerten:
(0)

Clinical Microbiology Market Size to Reach USD 4081.4 Million by 2028 at CAGR 3.6% - Valuates Reports

BANGALORE, India, March 21, 2022 /PRNewswire/ -- The Clinical Microbiology Market is Segmented by Product Type (Laboratory Instruments, Automated Culture Systems, Reagents), Applications (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, Other Diseases). The report covers global opportunity analysis, regional outlook, growth potential, industry forecast from 2022 to 2028.

Valuates_Reports_Logo

The global Clinical Microbiology market size is projected to reach USD 4081.4 Million by 2028, from USD 3171.1 Million in 2021, at a CAGR of 3.6% during 2022-2028.

Major Factors Driving The Growth Of The Clinical Microbiology Market Are:

Clinical microbiology market growth is expected to be driven by the rising incidence of infectious diseases, increasing pandemic and epidemic outbreaks, technological advancements, and increased funding and public-private investments for drug discovery.

Get your sample today: https://reports.valuates.com/request/sample/QYRE-Auto-29D239/Global_Clinical_Microbiology_Market

Trends Influencing The Growth Of Clinical Microbiology Market

The clinical microbiology market is expected to grow as the incidence of infectious diseases rises. Clinical microbiology laboratories play a critical role in improving infectious disease management. The clinical microbiology workflow has been greatly improved by syndrome-based sampling and molecular testing, as well as increased automation.

Historically, manual methods were used in culture-based microbiology laboratory testing, and automated methods (such as those that have revolutionized clinical chemistry and hematology in recent decades) were largely absent from the clinical microbiology laboratory. The adoption of automated methods for culture-based laboratory testing in clinical microbiology has been driven by increased demand for microbiology testing and standardization of sample-collection devices for microbiology culture due to rising pandemic and epidemic outbreaks, as well as a dwindling supply of microbiology technologists. This, in turn, is expected to propel the clinical microbiology market even further.

The clinical microbiology market is expected to grow due to the rise in respiratory diseases. Respiratory infections are one of the most common health problems in children around the world, and they are associated with significant morbidity and mortality. A wide range of microorganisms are potential respiratory pathogens; understanding the likely etiologic agents of respiratory infections can aid in disease management and surveillance. The clinical microbiology laboratory can provide valuable information on antimicrobial susceptibility and strain typing in addition to identifying specific pathogens.

However, the lack of qualified graduates and training programs, particularly in developing countries where demand for skilled professionals is rapidly increasing, may stymie market expansion. However, the introduction of automated systems into the market will eventually replace manually-operated traditional platforms, reducing the impact of a skills shortage.

Browse the Table of Contents and List of figures at: https://reports.valuates.com/reports/QYRE-Auto-29D239/global-clinical-microbiology

Clinical Microbiology Market Share Analysis:

Based on Region, North America is expected to be the most lucrative segment during the forecast period. The adoption of advanced clinical diagnostic techniques in the United States is fueled by the country's highly developed industrial and healthcare sectors. Furthermore, the presence of leading players and a strict regulatory framework is boosting the regional market growth.

Based on type, the reagents segment is expected to have the highest market share. Solutions, primers, master mixes, and kits used in various diagnostic assays are included in this segment.

Based on application, respiratory diseases are expected to be the most lucrative segment due to an increase in air pollution levels. In addition, respiratory diseases spread quickly among all infections due to the ease with which contagious pathogens can be transferred.

Download Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-29D239/Global_Clinical_Microbiology_Market

This report includes the following companies; we can also add the other companies as you want.

  • BioMerieux
  • Cepheid
  • Danaher
  • Bruker
  • Becton Dickinson
  • Hologic
  • Roche Diagnostics
  • Abbott
  • Others

Chapter Cost Request: https://reports.valuates.com/request/chaptercost/QYRE-Auto-29D239/Global_Clinical_Microbiology_Market

Buy Now for Single User + Covid-19 Impact: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-29D239&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS

- The global Microbiology Testing/Clinical Microbiology market size is projected to reach USD 4401.9 Million by 2028, from USD 3118 Million in 2021, at a CAGR of 4.6% during 2022-2028.

- The global Clinical Reference Laboratory Services market size is projected to reach USD 20420 Million by 2028, from USD 14260 Million in 2021, at a CAGR of 5.2% during 2022-2028.

- The global Antimicrobial Susceptibility Test market size is projected to reach USD 3001.4 Million by 2028, from USD 2431.4 Million in 2021, at a CAGR of 2.6% during 2022-2028.

- The global Clinical Laboratory Services market size is projected to reach USD 282960 Million by 2028, from USD 192650 Million in 2021, at a CAGR of 5.2% during 2022-2028.

-Global Infectious Disease Testing Using PCR for IVD Market Insights and Forecast to 2028

-Global Sleeping Sickness Testing Market Insights, Forecast to 2028

-Global Professional Diagnostics Market Insights and Forecast to 2028

-Global Pathology Devices Market Insights and Forecast to 2028

-Global Magnetic Separation Devices Market Insights, Forecast to 2028

-Global Single-mode Microplate Readers Market Insights and Forecast to 2028

To see the full list of related reports on the Clinical Microbiology

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources

CONTACT US:

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call +1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91 9945648335
Website: https://reports.valuates.com
Follow on Twitter - https://twitter.com/valuatesreports
Follow on Linkedin - https://in.linkedin.com/company/valuatesreports
Follow on Facebook - https://www.facebook.com/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg

© 2022 PR Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.